20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
- Needham analyst James Ricchiuti maintained MKS Instruments, Inc (NASDAQ:MKSI) with a Buy and cut the price target from $105 to $95.
- With growing signs of a deepening WFE spending downturn in 2023, he again reduced estimates for MKS, which will report Q3'22 results after the market close on November 2.
- In late September, he issued revised estimates for MKS, including the recently acquired Atotech business and a tempered outlook for the legacy MKS business.
- Since that time, there have been several negative data points, including a preannouncement from Applied Materials, Inc (NASDAQ: AMAT) and a weak 2023 WFE outlook from Lam Research Corp (NASDAQ: LRCX), both large customers of MKS, along with reports of reduced semi cap-ex from leading semi companies.
- The deteriorating WFE outlook comes at a time of new U.S. export restrictions for U.S. WFE and related parts and services sold in China.
- He re-rated MKS as shares have likely troughed in anticipation of reductions in Street estimates.
- Price Action: MKSI shares traded higher by 0.04% at $77.66 on the last check Friday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!